11Feb/16
E Luyer IBM ARticle

Practical Use of the Internet of Things in Healthcare

By: Eric Luyer, Market Research Analyst

Reading my daily newspaper as well as checking Social Media, there is a lot of information around the new concept of “Internet of Things” (IoT). This term encompasses the latest technology around connected devices within a network and includes all the valuable, collected information from data and intelligence from all kinds of different devices.  Linked to these new developments, you will find companies that are focusing on this data and building new, highly relevant applications in specific markets or for specific communities.

This is for sure the case within the medical and healthcare environments.  In fact, it is interesting to see how the concept of IoT is changing healthcare strategies, business models and affecting healthcare operations. In this environment, we are talking more and more about the Internet of Medical Things.  Let’s look at some examples that have been discussed in the media and are currently available in daily healthcare practices. Continue reading

08Feb/16
Source: IBM.com

PART 2: IBM’s Grand Vision for Better Healthcare

By: Ellyn McMullin, Research Associate and Daniel R. Matlis, President

How IBM Wants to Transform the Healthcare Industry – Part 2 

As changes in Healthcare reimbursement moves from a fee-for-service to a fee-for-value model, there is a growing need to capture tremendous amounts of data to be analyzed and communicated in an uncomplicated manner.   It is the vision of IBM Watson Health bring together clinical, research and social data from a diverse range of health sources, creating a secure, cloud-based data sharing hub, powered by the most advanced cognitive and analytic technologies.

As IBM’s vision continues to evolve we spoke with Pete Karns, IBM VP, Offerings, Internet of Things, Michael Fahey , Offering Manager for Exogenous Data,  IBM Watson Health and Andy Stanford-Clark, IBM (UK) Distinguished Engineer, Master Inventor, Internet of Things to learn about the impact of the Internet of Things (IoT) and Internet of Medical Things (IoMT) on Healthcare.

Part 1 of this 2 part article concentrated on how the Healthcare industry will benefit from transforming itself; Part 2 looks at what is needed (both technologically and otherwise) and what challenges are ahead to improving patient outcomes and quality of care while lowering cost.

To continue reading, please register to receive a PDF of this article in its entirety.

02Feb/16
Embrace-150x200

FDA and Industry Embrace Highest Quality for Medical Products

By:  Daniel R. Matlis, President

Historically, interactions between industry and the FDA have been described as complex, challenging and even adversarial. Many a time, our firm has been asked to serve as an “anonymizer” for a medical device company that had a question for the FDA, but was concerned about interacting with the agency directly.

Would interactions be different if meetings between the agency and industry shutterstock_195838178 HUG FOR MDIC Article
stakeholders started with a hug? They did at the most recent Case for Quality Forum where industry and the FDA literally embraced, stating that providing medical products of the highest quality is their main focus.

The Case for Quality (CfQ) Forum consistently provides an open venue to discuss and exchange ideas on improving medical device product quality. The Case for Quality program was created to facilitate ongoing dialogue that will ultimately benefit patients, providers and the medical technology community. The initiative brings together industry stakeholders – including the U.S. Food and Drug Administration, medical device manufacturers, payers, providers, industry advisors and patient advocates. Continue reading

25Jan/16
Source: http://www.ibm.com/smarterplanet/us/en/ibmwatson/health/index.html

IBM’s Grand Vision for Better Healthcare

By: Ellyn McMullin, Research Associate and Daniel R. Matlis, President

How IBM Wants to Transform the Healthcare Industry – Part 1 

IBM has made a number of key announcements recently regarding the formation of a new business unit called Watson Health as well as a Watson IoT unit.

It is the vision of IBM Watson Healthto bring together clinical, research and social data from a diverse range of health sources, creating a secure, cloud-based data sharing hub, powered by the most advanced cognitive and analytic technologies and fed by the Internet of Things.  As we previously discussed in “IBM wants to use Watson to fix a Disconnected Healthcare System” Watson’s unique capabilities have tremendous potential in the Healthcare industry.

Continue reading

30Nov/15
shift image

Shift is Happening Now

By Daniel R. Matlis, President

What Can Pharma CIOs do to Enable Innovation

What is the role of a CIO in a Pharma / Life-Science company?  Traditionally, the role of the CIO has been to manage the IT portfolio, implement systems, manage infrastructure and control IT costs to support the business.

With the unprecedented rate of shift the industry is experiencing, CIO’s can no longer simply be tasked with managing portfolios and budgets.

This was evident at the 2015 CIO Innovation Summit in Kyoto, Japan on October 20th.

There, Executives from leading organizations across the Life-Sciences ecosystem in Asia converged at the Ritz Carlton in Kyoto to learn about industry trends and share success stories and current best practices (cBPs).

Key themes at the event included innovation, transformation, collaboration and connectivity.  The event was hosted by BIOVIA – Dassault Systemes and brought together top executives from:

  • Astellas Pharma
  • Bridgestone
  • Bionet
  • Daichi Sankyo Biovia
  • Everlight Chemical
  • Genesis Genetics Asia
  • IPCA Laboratories
  • Samsung Biologics
  • Shionogi &Co
  • Sumitomo Danippon
  • Takeda Pharmaceuticals
  • Mitsui Chemicals
  • WuXi Apptech

Max Carnecchia, BIOVIA’s CEO, set the tone for the event in his opening remarks. His message: “By transforming the pharmaceutical industry through innovation, collaboration and connectivity, we can streamline end-to-end manufacturing, enhance quality and improve compliance in today’s challenging regulatory and risk environment.”

To learn more about illuminating dark data, please click here for a PDF copy of the entire Event Brief.